ARTBIO is a clinical-stage radiopharmaceutical company that develops new alpha radioligand therapies (ARTs). ARTBIO's approach uses tumor-specific targets and the best alpha-precursor isotope (Pb212) to develop safe and effective therapeutics.

<p>ARTBIO is a clinical-stage radiopharmaceutical company that develops new alpha radioligand therapies (ARTs). ARTBIO&#39;s approach uses tumor-specific targets and the best alpha-precursor isotope (Pb212) to develop safe and effective therapeutics. ARTBIO is working with SpectronRx to develop a new prostate cancer therapy called AB001.</p>


ARTBIO

Founded: 2021
Location: Oslo, Norway
Employee range: 1-50
Clinical stage: Clin0
Therapy area: Prostate Cancer
Drug types: ONC
Lead product: AB001
Funding: 10-100M

Senior Scientist, In Vivo Biology

ARTBIO

Drug notes:

About:

Jobs: